Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Recro Pharma Inc (NASDAQ:REPH)

9.16
Delayed Data
As of 3:59pm ET
 +0.03 / +0.33%
Today’s Change
5.59
Today|||52-Week Range
17.25
+1.78%
Year-to-Date
Insiders Sell Alphabet, Facebook
Aug 19 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close9.13
Today’s open9.41
Day’s range9.16 - 9.50
Volume21,701
Average volume (3 months)30,382
Market cap$108.2M
Dividend yield--
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,735.71%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales1.52
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
VVUSVIVUS Inc0.000.00%
MRTXMirati Therapeutics ...-0.34-6.39%
MDGLMadrigal Pharmaceuti...+0.17+1.82%
ASMBAssembly Biosciences...+0.11+1.71%
Data as of 3:59pm ET, 08/25/2016

Financials

Next reporting dateNovember 11, 2016
EPS forecast (this quarter)-$0.98
Annual revenue (last year)$52.0M
Annual profit (last year)$3.0M
Net profit margin5.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri Henwood
Chief Financial Officer
Michael Celano
Corporate headquarters
Malvern, Pennsylvania

Forecasts

Partner Offers

Search for Jobs